.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A retrospective study evaluates contrast-associated acute kidney injury (CA-AKI) incidence in oncology patients receiving active chemotherapy with preserved renal function, highlighting low overall risk and timing considerations.
A clinical overview of periorbital ecthyma gangrenosum in neutropenic patients, highlighting how identification within 24 hours and prompt antipseudomonal therapy permit complete medical resolution and spare patients from aggressive surgical debridement.
China's Order 818 establishes a pioneering dual-track regulatory framework for cell and gene therapies. By decoupling hospital-based clinical translation from traditional drug pathways, it fosters rapid biomedical innovation while enforcing strict exit criteria and comprehensive 30-year patient safety oversight.
Prognostic testing in early breast cancer offers a personalized approach to adjuvant therapy. An artificial intelligence prognostic assay developed in India stratifies low-risk patients who can safely omit adjuvant chemotherapy, reducing unnecessary toxicities and lowering overall healthcare expenditure.
The prospective NISTIPS TRITICC-4 study evaluates whether transjugular intrahepatic portosystemic shunt (TIPS) preserves liver function and reduces bleeding risk in hepatocellular carcinoma patients receiving first-line atezolizumab and bevacizumab across 25 specialized German centers.
